Quarterly report [Sections 13 or 15(d)]

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY

v3.25.3
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Common Stock
Additional Paid-in- Capital
Treasury Stock
Accumulated Other Comprehensive Income
Accumulated Deficit
Total
Beginning balance at Dec. 30, 2023 $ 60 $ 312,874 $ (11,912) $ 783 $ (188,974) $ 112,831
Beginning balance (in shares) at Dec. 30, 2023 56,303          
Increase (Decrease) in Stockholders' Equity            
Net loss         (6,478) (6,478)
Issuance of shares in connection with restricted stock units vesting $ 1 (323)       (322)
Issuance of shares in connection with restricted stock units vesting (in shares) 243          
Issuance of shares in connection with BOD fees   8       8
Officers and directors stock purchase plan (in shares) 3          
Issuance of shares in connection with ESPP   202       202
Issuance of shares in connection with ESPP (in shares) 75          
Share-based compensation   2,824       2,824
Foreign currency adjustments       87   87
Ending balance at Mar. 30, 2024 $ 61 315,585 (11,912) 870 (195,452) 109,152
Ending balance (in shares) at Mar. 30, 2024 56,624          
Beginning balance at Dec. 30, 2023 $ 60 312,874 (11,912) 783 (188,974) 112,831
Beginning balance (in shares) at Dec. 30, 2023 56,303          
Increase (Decrease) in Stockholders' Equity            
Net loss           (25,183)
Foreign currency adjustments           87
Ending balance at Sep. 28, 2024 $ 61 322,337 (11,912) 870 (214,157) 97,199
Ending balance (in shares) at Sep. 28, 2024 57,386          
Beginning balance at Mar. 30, 2024 $ 61 315,585 (11,912) 870 (195,452) 109,152
Beginning balance (in shares) at Mar. 30, 2024 56,624          
Increase (Decrease) in Stockholders' Equity            
Net loss         (8,687) (8,687)
Issuance of shares in connection with restricted stock units vesting   (106)       (106)
Issuance of shares in connection with restricted stock units vesting (in shares) 455          
Issuance of shares in connection with BOD fees   11       11
Issuance of shares in connection with BOD fees (in shares) 7          
Officers and directors stock purchase plan   3       3
Officers and directors stock purchase plan (in shares) 2          
Share-based compensation   3,517       3,517
Ending balance at Jun. 29, 2024 $ 61 319,010 (11,912) 870 (204,139) 103,890
Ending balance (in shares) at Jun. 29, 2024 57,088          
Increase (Decrease) in Stockholders' Equity            
Net loss         (10,018) (10,018)
Issuance of shares in connection with restricted stock units vesting   (32)       (32)
Issuance of shares in connection with restricted stock units vesting (in shares) 97          
Issuance of shares in connection with BOD fees   12       12
Issuance of shares in connection with BOD fees (in shares) 12          
Officers and directors stock purchase plan   3       3
Officers and directors stock purchase plan (in shares) 4          
Issuance of shares in connection with ESPP   157       157
Issuance of shares in connection with ESPP (in shares) 185          
Share-based compensation   3,187       3,187
Foreign currency adjustments           0
Ending balance at Sep. 28, 2024 $ 61 322,337 (11,912) 870 (214,157) 97,199
Ending balance (in shares) at Sep. 28, 2024 57,386          
Beginning balance at Dec. 28, 2024 $ 61 325,546 (11,912) 1,055 (229,575) 85,175
Beginning balance (in shares) at Dec. 28, 2024 57,454          
Increase (Decrease) in Stockholders' Equity            
Net loss         (15,283) (15,283)
Issuance of shares in connection with restricted stock units vesting $ 1 (396)       (395)
Issuance of shares in connection with restricted stock units vesting (in shares) 715          
Issuance of shares in connection with BOD fees   11       11
Issuance of shares in connection with BOD fees (in shares) 11          
Officers and directors stock purchase plan (in shares) 1          
Issuance of shares in connection with ESPP   96       96
Issuance of shares in connection with ESPP (in shares) 114          
Share-based compensation   3,166       3,166
Ending balance at Mar. 29, 2025 $ 62 328,423 (11,912) 1,055 (244,858) 72,770
Ending balance (in shares) at Mar. 29, 2025 58,295          
Beginning balance at Dec. 28, 2024 $ 61 325,546 (11,912) 1,055 (229,575) 85,175
Beginning balance (in shares) at Dec. 28, 2024 57,454          
Increase (Decrease) in Stockholders' Equity            
Net loss           (38,879)
Foreign currency adjustments           0
Ending balance at Sep. 27, 2025 $ 64 343,404 (11,912) 1,055 (268,454) 64,157
Ending balance (in shares) at Sep. 27, 2025 69,356          
Beginning balance at Mar. 29, 2025 $ 62 328,423 (11,912) 1,055 (244,858) 72,770
Beginning balance (in shares) at Mar. 29, 2025 58,295          
Increase (Decrease) in Stockholders' Equity            
Net loss         (12,711) (12,711)
Issuance of shares in connection with restricted stock units vesting $ 1 (69)       (68)
Issuance of shares in connection with restricted stock units vesting (in shares) 451          
Issuance of shares in connection with BOD fees   14       14
Issuance of shares in connection with BOD fees (in shares) 15          
Share-based compensation   2,441       2,441
Ending balance at Jun. 28, 2025 $ 63 330,809 (11,912) 1,055 (257,569) 62,446
Ending balance (in shares) at Jun. 28, 2025 58,761          
Increase (Decrease) in Stockholders' Equity            
Net loss         (10,885) (10,885)
Issuance of shares in connection with restricted stock units vesting   (53)       (53)
Issuance of shares in connection with restricted stock units vesting (in shares) 163          
Issuance of shares in connection with BOD fees   15       15
Issuance of shares in connection with BOD fees (in shares) 20          
Issuance of shares in connection with ESPP   57       57
Issuance of shares in connection with ESPP (in shares) 92          
Issuance of shares in connection with purchase agreement $ 1 10,732       10,733
Issuance of shares in connection with purchase agreement (in shares) 10,320          
Issuance costs in connection with purchase agreement   (383)       (383)
Share-based compensation   2,227       2,227
Foreign currency adjustments           0
Ending balance at Sep. 27, 2025 $ 64 $ 343,404 $ (11,912) $ 1,055 $ (268,454) $ 64,157
Ending balance (in shares) at Sep. 27, 2025 69,356